Targeting acute leukemia by lipid-antigen specific T cells restricted for CD1
April 6, 2018 (1:30 PM) Targeting acute leukemia by lipid-antigen specific T cells restricted for CD1 Giulia Casorati Experimental Immunology Unit, DIBIT, San Raffaele Scientific Institute Milan
Ruolo della terapia con PARP inibitori nel trattamento del tumore ovarico
February 21, 2018 (1:30 PM) Ruolo della terapia con PARP inibitori nel trattamento del tumore ovarico Domenica Lorusso Chirurgia Ginecologica Fondazione IRCCS Istituto Nazionale dei Tumori Milan
Global Medicinal Chemistry & GPCR Leaders Summit
27-28 novembre London, UK Global Medicinal Chemistry & GPCR Leaders Summit Oral presentation: The systematic use of highly profiled antitumor agents in probing the sensitivity contexts of cancer cells and assessing the validity of target combinations
European Molecular Biology Laboratory Conference
5-8 novembre Heidelberg, Germany European Molecular Biology Laboratory Conference
XIX Congresso Nazionale AIOM
27-29 ottobre Roma, Italy XIX Congresso Nazionale AIOM
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications
26-30 ottobre Philadelphia, Pennsylvania AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications
IMI K4DD Conference 2017. Binding kinetics: time is of the essence
16-18 ottobre Berlin, Germany IMI K4DD Conference 2017. Binding kinetics: time is of the essence
Cancer Bio-Immunotherapy – XV NIBIT meeting
3-7 ottobre Siena, Italy Cancer Bio-Immunotherapy – XV NIBIT meeting
XXXV Conferenza Nazionale di citometria
3-6 ottobre Paestum, Italy XXXV Conferenza Nazionale di citometria
8th World ADC Congress
20-22 settembre San Diego, CA 8th World ADC Congress Abstract: Thienoindoles, a novel class of potent toxins for antibody drug conjugates
